These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28885433)

  • 1. Put away your microscopes: the ependymoma molecular era has begun.
    Mack SC; Taylor MD
    Curr Opin Oncol; 2017 Nov; 29(6):443-447. PubMed ID: 28885433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Ependymoma.
    Vitanza NA; Partap S
    J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric ependymomas: will molecular biology change patient management?
    Grill J; Bergthold G; Ferreira C
    Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymoma.
    Gerstner ER; Pajtler KW
    Semin Neurol; 2018 Feb; 38(1):104-111. PubMed ID: 29548057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.
    Gojo J; Englinger B; Jiang L; Hübner JM; Shaw ML; Hack OA; Madlener S; Kirchhofer D; Liu I; Pyrdol J; Hovestadt V; Mazzola E; Mathewson ND; Trissal M; Lötsch D; Dorfer C; Haberler C; Halfmann A; Mayr L; Peyrl A; Geyeregger R; Schwalm B; Mauermann M; Pajtler KW; Milde T; Shore ME; Geduldig JE; Pelton K; Czech T; Ashenberg O; Wucherpfennig KW; Rozenblatt-Rosen O; Alexandrescu S; Ligon KL; Pfister SM; Regev A; Slavc I; Berger W; Suvà ML; Kool M; Filbin MG
    Cancer Cell; 2020 Jul; 38(1):44-59.e9. PubMed ID: 32663469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of childhood ependymoma.
    Merchant TE
    Oncology (Williston Park); 2002 May; 16(5):629-42, 644; discussion 645-6, 648. PubMed ID: 12108890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.
    Delgado-López PD; Corrales-García EM; Alonso-García E; García-Leal R; González-Rodrigálvarez R; Araus-Galdós E; Martín-Alonso J
    Clin Transl Oncol; 2019 Nov; 21(11):1450-1463. PubMed ID: 30868390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing landscape of ependymomas: diagnostic and treatment approaches.
    Germano IM; Kasper EM
    J Neurosurg Sci; 2018 Feb; 62(1):36-37. PubMed ID: 28945056
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the biology and treatment of pediatric central nervous system tumors.
    Vitanza NA; Cho YJ
    Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Clinical Challenges in Childhood Ependymoma: A Focused Review.
    Merchant TE
    J Clin Oncol; 2017 Jul; 35(21):2364-2369. PubMed ID: 28640697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Ependymoma in Children, Adolescents and Young Adults.
    Thorp N; Gandola L
    Clin Oncol (R Coll Radiol); 2019 Mar; 31(3):162-170. PubMed ID: 30616927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the classification and treatment of pediatric brain tumors.
    Fangusaro J; Bandopadhayay P
    Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current therapy and the evolving molecular landscape of paediatric ependymoma.
    Khatua S; Ramaswamy V; Bouffet E
    Eur J Cancer; 2017 Jan; 70():34-41. PubMed ID: 27866097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma.
    Lummus SC; Donson AM; Gowan K; Jones KL; Vibhakar R; Foreman NK; Kleinschmidt-DeMasters BK
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28548702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma.
    Tabori U; Wong V; Ma J; Shago M; Alon N; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
    Br J Cancer; 2008 Oct; 99(7):1129-35. PubMed ID: 18797459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
    Pajtler KW; Mack SC; Ramaswamy V; Smith CA; Witt H; Smith A; Hansford JR; von Hoff K; Wright KD; Hwang E; Frappaz D; Kanemura Y; Massimino M; Faure-Conter C; Modena P; Tabori U; Warren KE; Holland EC; Ichimura K; Giangaspero F; Castel D; von Deimling A; Kool M; Dirks PB; Grundy RG; Foreman NK; Gajjar A; Korshunov A; Finlay J; Gilbertson RJ; Ellison DW; Aldape KD; Merchant TE; Bouffet E; Pfister SM; Taylor MD
    Acta Neuropathol; 2017 Jan; 133(1):5-12. PubMed ID: 27858204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
    Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
    Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of paediatric central nervous system tumours.
    Chiang JC; Ellison DW
    J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric ependymoma: current treatment and newer therapeutic insights.
    Khatua S; Mangum R; Bertrand KC; Zaky W; McCall D; Mack SC
    Future Oncol; 2018 Dec; 14(30):3175-3186. PubMed ID: 30418040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.